ABPI suspends Novo Nordisk membership
Pharmaceutical company Novo Nordisk has been suspended as a member of the Association of the British Pharmaceutical Industry (ABPI) for two years.
Pharmaceutical company Novo Nordisk has been suspended as a member of the Association of the British Pharmaceutical Industry (ABPI) for two years.
New clinical data has indicated that Ozempic (semaglutide), a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by pharmaceutical company Novo Nordisk, is effective for sustained weight loss.
An Expert Clinic session focusing on obesity will take place at the Aesthetics Conference and Exhibition (ACE) 2019 on Saturday March 2 from 3.30pm.
We bring you the most up-to-date information for the Aesthetics community across a variety of media, including; news, webinars, podcasts, the Journal, reports, interviews and more!
aesthetics Journal
The Aesthetics Journal is the leading monthly publication for the medical aesthetics specialty. It is peer reviewed and spans an incredible volume of topics. Become a member today to receive the monthly print and digital Journal.
0203 096 1228
2nd Floor, Regal House, 70 London Road
Twickenham TW1 3QS, United Kingdom
© 2023 Easyfairs UK Ltd | Registered in England No. 05067979